These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

660 related items for PubMed ID: 17289396

  • 1. Post-transplant survival after lowering fixed pulmonary hypertension using left ventricular assist devices.
    Zimpfer D, Zrunek P, Sandner S, Schima H, Grimm M, Zuckermann A, Wolner E, Wieselthaler G.
    Eur J Cardiothorac Surg; 2007 Apr; 31(4):698-702. PubMed ID: 17289396
    [Abstract] [Full Text] [Related]

  • 2. Does pretransplant left ventricular assist device therapy improve results after heart transplantation in patients with elevated pulmonary vascular resistance?
    Liden H, Haraldsson A, Ricksten SE, Kjellman U, Wiklund L.
    Eur J Cardiothorac Surg; 2009 Jun; 35(6):1029-34; discussion 1034-5. PubMed ID: 19211259
    [Abstract] [Full Text] [Related]

  • 3. Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates.
    Zimpfer D, Zrunek P, Roethy W, Czerny M, Schima H, Huber L, Grimm M, Rajek A, Wolner E, Wieselthaler G.
    J Thorac Cardiovasc Surg; 2007 Mar; 133(3):689-95. PubMed ID: 17320566
    [Abstract] [Full Text] [Related]

  • 4. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
    John R, Pagani FD, Naka Y, Boyle A, Conte JV, Russell SD, Klodell CT, Milano CA, Rogers J, Farrar DJ, Frazier OH.
    J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
    [Abstract] [Full Text] [Related]

  • 5. Normalization of high pulmonary vascular resistance with LVAD support in heart transplantation candidates.
    Salzberg SP, Lachat ML, von Harbou K, Zünd G, Turina MI.
    Eur J Cardiothorac Surg; 2005 Feb; 27(2):222-5. PubMed ID: 15691674
    [Abstract] [Full Text] [Related]

  • 6. Implantable left ventricular assist device for treatment of pulmonary hypertension in candidates for orthotopic heart transplantation-a preliminary study.
    Martin J, Siegenthaler MP, Friesewinkel O, Fader T, van de Loo A, Trummer G, Berchtold-Herz M, Beyersdorf F.
    Eur J Cardiothorac Surg; 2004 Jun; 25(6):971-7. PubMed ID: 15144997
    [Abstract] [Full Text] [Related]

  • 7. Reversible pulmonary hypertension in heart transplant candidates: to transplant or not to transplant.
    Klotz S, Wenzelburger F, Stypmann J, Welp H, Drees G, Schmid C, Scheld HH.
    Ann Thorac Surg; 2006 Nov; 82(5):1770-3. PubMed ID: 17062245
    [Abstract] [Full Text] [Related]

  • 8. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
    John R, Kamdar F, Liao K, Colvin-Adams M, Boyle A, Joyce L.
    Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
    [Abstract] [Full Text] [Related]

  • 9. Reversibility of fixed pulmonary hypertension in left ventricular assist device support recipients.
    Mikus E, Stepanenko A, Krabatsch T, Loforte A, Dandel M, Lehmkuhl HB, Hetzer R, Potapov EV.
    Eur J Cardiothorac Surg; 2011 Oct; 40(4):971-7. PubMed ID: 21354812
    [Abstract] [Full Text] [Related]

  • 10. Pre-existing pulmonary hypertension in patients with end-stage heart failure: impact on clinical outcome and hemodynamic follow-up after orthotopic heart transplantation.
    Goland S, Czer LS, Kass RM, De Robertis MA, Mirocha J, Coleman B, Capelli C, Raissi S, Cheng W, Fontana G, Trento A.
    J Heart Lung Transplant; 2007 Apr; 26(4):312-8. PubMed ID: 17403470
    [Abstract] [Full Text] [Related]

  • 11. Prostaglandin E1 testing in heart failure-associated pulmonary hypertension enables transplantation: the PROPHET study.
    von Scheidt W, Costard-Jaeckle A, Stempfle HU, Deng MC, Schwaab B, Haaff B, Naegele H, Mohacsi P, Trautnitz M, PROPHET Study Group.
    J Heart Lung Transplant; 2006 Sep; 25(9):1070-6. PubMed ID: 16962468
    [Abstract] [Full Text] [Related]

  • 12. Left ventricular assist device destination therapy versus extended criteria cardiac transplant.
    Daneshmand MA, Rajagopal K, Lima B, Khorram N, Blue LJ, Lodge AJ, Hernandez AF, Rogers JG, Milano CA.
    Ann Thorac Surg; 2010 Apr; 89(4):1205-9; discussion 1210. PubMed ID: 20338335
    [Abstract] [Full Text] [Related]

  • 13. Left ventricular assist device support of medically unresponsive pulmonary hypertension and aortic insufficiency.
    Adamson RM, Dembitsky WP, Jaski BE, Daily PO, Moreno R, Kim JC, Sono J, Akasaka T, Hoagland PM, Gordon JB.
    ASAIO J; 1997 Apr; 43(4):365-9. PubMed ID: 9242955
    [Abstract] [Full Text] [Related]

  • 14. Allosensitization in bridge to transplant Novacor left ventricular assist device patients: analysis of long-term outcomes with regard to acute rejection and chronic allograft vasculopathy.
    Kirsch L, Timmermans T, Van Caenegem O, Gurne O, Noirhomme P, Jacquet LM, Latinne D, Poncelet AJ.
    Eur J Cardiothorac Surg; 2008 Aug; 34(2):268-74; discussion 274. PubMed ID: 18456505
    [Abstract] [Full Text] [Related]

  • 15. Age and outcome after continuous-flow left ventricular assist device implantation as bridge to transplantation.
    Sandner SE, Zimpfer D, Zrunek P, Rajek A, Schima H, Dunkler D, Zuckermann AO, Wieselthaler GM.
    J Heart Lung Transplant; 2009 Apr; 28(4):367-72. PubMed ID: 19332264
    [Abstract] [Full Text] [Related]

  • 16. Impact of left ventricular assist device bridging on posttransplant outcomes.
    Pal JD, Piacentino V, Cuevas AD, Depp T, Daneshmand MA, Hernandez AF, Felker GM, Lodge AJ, Rogers JG, Milano CA.
    Ann Thorac Surg; 2009 Nov; 88(5):1457-61; discussion 1461. PubMed ID: 19853092
    [Abstract] [Full Text] [Related]

  • 17. The influence of infection on survival and successful transplantation in patients with left ventricular assist devices.
    Argenziano M, Catanese KA, Moazami N, Gardocki MT, Weinberg AD, Clavenna MW, Rose EA, Scully BE, Levin HR, Oz MC.
    J Heart Lung Transplant; 1997 Aug; 16(8):822-31. PubMed ID: 9286774
    [Abstract] [Full Text] [Related]

  • 18. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.
    Lietz K, Long JW, Kfoury AG, Slaughter MS, Silver MA, Milano CA, Rogers JG, Naka Y, Mancini D, Miller LW.
    Circulation; 2007 Jul 31; 116(5):497-505. PubMed ID: 17638928
    [Abstract] [Full Text] [Related]

  • 19. End-organ function in patients on long-term circulatory support with continuous- or pulsatile-flow assist devices.
    Radovancevic B, Vrtovec B, de Kort E, Radovancevic R, Gregoric ID, Frazier OH.
    J Heart Lung Transplant; 2007 Aug 31; 26(8):815-8. PubMed ID: 17692785
    [Abstract] [Full Text] [Related]

  • 20. Medically refractory pulmonary hypertension: treatment with nonpulsatile left ventricular assist devices.
    Etz CD, Welp HA, Tjan TD, Hoffmeier A, Weigang E, Scheld HH, Schmid C.
    Ann Thorac Surg; 2007 May 31; 83(5):1697-705. PubMed ID: 17462383
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.